Suppr超能文献

肝细胞选择培养基富集的肝癌细胞甲胎蛋白和CD44呈阳性。

Hepatocyte selection medium-enriched hepatocellular carcinoma cells are positive for α-fetoprotein and CD44.

作者信息

Tomizawa Minoru, Shinozaki Fuminobu, Motoyoshi Yasufumi, Sugiyama Takao, Yamamoto Shigenori, Ishige Naoki

机构信息

Department of Gastroenterology, National Hospital Organization, Shimoshizu Hospital, Yotsukaido, Chiba 284-0003, Japan.

Department of Radiology, National Hospital Organization, Shimoshizu Hospital, Yotsukaido, Chiba 284-0003, Japan.

出版信息

Oncol Lett. 2017 Jul;14(1):899-902. doi: 10.3892/ol.2017.6239. Epub 2017 May 24.

Abstract

Tissues surrounding hepatocellular carcinomas (HCCs) lack glucose. Hepatocyte selection medium (HSM) is deficient in glucose and is supplemented with galactose. HCC cells were cultured in HSM to investigate the stem cell markers α-fetoprotein (AFP) and cluster of differentiation 44 (CD44). HCC cells (HLF and PLC/PRF/5 cells) were cultured in HSM. Viable cell numbers were determined on days 0 and 7 following culture in HSM. RNA was isolated and subjected to reverse transcription-quantitative PCR (RT-qPCR) to analyze the mRNA expression levels of AFP and CD44. Immunostaining was performed to analyze the protein levels of AFP and CD44. The number of viable cells was significantly decreased on day 7 following culture in HSM. The expression levels of AFP and CD44 increased on day 7 as assessed using RT-qPCR. Immunostaining confirmed the results of RT-qPCR analysis. The number of viable HCC cells was decreased in HSM, whereas the expression levels of AFP and CD44 increased. Therefore, HSM is potentially useful for the enrichment of HCC cells with cancer stem cell characteristics.

摘要

肝细胞癌(HCC)周围的组织缺乏葡萄糖。肝细胞选择培养基(HSM)不含葡萄糖,并添加了半乳糖。将HCC细胞培养在HSM中,以研究干细胞标志物甲胎蛋白(AFP)和分化簇44(CD44)。将HCC细胞(HLF和PLC/PRF/5细胞)培养在HSM中。在HSM中培养0天和7天后测定活细胞数量。分离RNA并进行逆转录定量PCR(RT-qPCR),以分析AFP和CD44的mRNA表达水平。进行免疫染色以分析AFP和CD44的蛋白水平。在HSM中培养7天后,活细胞数量显著减少。使用RT-qPCR评估,AFP和CD44的表达水平在第7天增加。免疫染色证实了RT-qPCR分析的结果。在HSM中,活的HCC细胞数量减少,而AFP和CD44的表达水平增加。因此,HSM可能有助于富集具有癌症干细胞特征的HCC细胞。

相似文献

本文引用的文献

1
Research progress and prospects of markers for liver cancer stem cells.肝癌干细胞标志物的研究进展与展望
World J Gastroenterol. 2015 Nov 14;21(42):12190-6. doi: 10.3748/wjg.v21.i42.12190.
3
Screening for Viral Hepatitis and Hepatocellular Cancer.病毒性肝炎和肝细胞癌的筛查
Surg Clin North Am. 2015 Oct;95(5):1013-21. doi: 10.1016/j.suc.2015.05.005. Epub 2015 Jun 16.
4
CD44 expression in patients with combined hepatocellular cholangiocarcinoma.肝内胆管癌合并肝细胞癌患者的CD44表达
Ann Surg Treat Res. 2015 Jul;89(1):9-16. doi: 10.4174/astr.2015.89.1.9. Epub 2015 Jun 11.
6
Clonogenically Culturing and Expanding CD34+ Liver Cancer Stem Cells in Vitro.体外克隆培养和扩增CD34+肝癌干细胞
Stem Cells Dev. 2015 Jul 1;24(13):1506-14. doi: 10.1089/scd.2015.0022. Epub 2015 May 12.
9
Intratumor heterogeneity in hepatocellular carcinoma.肝细胞癌中的肿瘤内异质性。
Clin Cancer Res. 2015 Apr 15;21(8):1951-61. doi: 10.1158/1078-0432.CCR-14-0122. Epub 2014 Sep 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验